- $1.30bn
- $3.02bn
- $3.26bn
- 83
- 94
- 38
- 84
Annual balance sheet for Adapthealth, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K/A | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 100 | 150 | 46.3 | 77.1 | 110 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 171 | 360 | 359 | 389 | 408 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 363 | 670 | 585 | 649 | 756 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 110 | 546 | 622 | 638 | 618 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,813 | 5,250 | 5,220 | 4,509 | 4,487 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 422 | 500 | 456 | 537 | 567 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1,459 | 3,189 | 3,068 | 3,050 | 2,916 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 355 | 2,062 | 2,151 | 1,458 | 1,571 |
| Total Liabilities & Shareholders' Equity | 1,813 | 5,250 | 5,220 | 4,509 | 4,487 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |